0001847173-21-000001.txt : 20210222 0001847173-21-000001.hdr.sgml : 20210222 20210219200328 ACCESSION NUMBER: 0001847173-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210222 DATE AS OF CHANGE: 20210219 EFFECTIVENESS DATE: 20210222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Excision BioTherapeutics Inc CENTRAL INDEX KEY: 0001847173 IRS NUMBER: 473658697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-390027 FILM NUMBER: 21657927 BUSINESS ADDRESS: STREET 1: 988 MARKET STREET, SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94102 BUSINESS PHONE: (404) 229-1162 MAIL ADDRESS: STREET 1: 988 MARKET STREET, SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94102 D 1 primary_doc.xml X0708 D LIVE 0001847173 Excision BioTherapeutics Inc 988 MARKET STREET, SECOND FLOOR SAN FRANCISCO CA CALIFORNIA 94102 (404) 229-1162 DELAWARE None None Corporation true Daniel Dornbusch c/o Excision BioTherapeutics Inc 988 Market Street, Second Floor San Francisco CA CALIFORNIA 94102 Executive Officer Director Vasudev Bailey c/o Excision BioTherapeutics Inc 988 Market Street, Second Floor San Francisco CA CALIFORNIA 94102 Director William Carson c/o Excision BioTherapeutics Inc 988 Market Street, Second Floor San Francisco CA CALIFORNIA 94102 Director Ashok Krishnamurthi c/o Excision BioTherapeutics Inc 988 Market Street, Second Floor San Francisco CA CALIFORNIA 94102 Director Biotechnology Decline to Disclose 06b false 2021-02-03 false true false 1 63757341 60738974 3018367 false 32 0 0 0 false Excision BioTherapeutics Inc /s/ Daniel Dornbusch Daniel Dornbusch Chief Executive Officer 2021-02-19